Olema Pharmaceuticals, Inc. (OLMA)

27.14 -2.05 (-7.02%) USD  |  NASDAQ  |  Jan 16, 16:00
27.10 -0.04 (-0.15%) After-Hours: 20:00
More

Olema Pharmaceuticals Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for OLMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade
Cogent Biosciences, Inc. --
Replimune Group, Inc. --
Genprex, Inc. --